Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Dow
Medtronic
Deloitte
Cipla
Queensland Health
Express Scripts
Covington
Teva

Generated: August 21, 2017

DrugPatentWatch Database Preview

Insulin purified pork; insulin susp isophane purified pork - Generic Drug Details

« Back to Dashboard

What are the generic sources for insulin purified pork; insulin susp isophane purified pork and what is the scope of insulin purified pork; insulin susp isophane purified pork freedom to operate?

Insulin purified pork; insulin susp isophane purified pork
is the generic ingredient in one branded drug marketed by Novo Nordisk Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are thirty-eight drug master file entries for insulin purified pork; insulin susp isophane purified pork.

Summary for Generic Name: insulin purified pork; insulin susp isophane purified pork

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list38
Clinical Trials: see list4,251
Drug Prices:see low prices
DailyMed Link:insulin purified pork; insulin susp isophane purified pork at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc
INSULIN NORDISK MIXTARD (PORK)
insulin purified pork; insulin susp isophane purified pork
INJECTABLE;INJECTION018195-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Argus Health
US Department of Justice
Citi
Moodys
Teva
Cantor Fitzgerald
McKesson
AstraZeneca
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot